Clinical Trials Directory

Trials / Completed

CompletedNCT00678184

The Effect of Atorvastatin on Renal Function in Healthy Subjects During Normal and High Sodium Intake

The Effect of Acute HMG-CoA-Reductase Inhibition (Atorvastatin) on Renal Sodium Excretion, Renal Hemodynamics, Tubular Function and Vasoactive Hormones in Healthy Subjects During Normal and High Sodium Intake

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Regional Hospital Holstebro · Academic / Other
Sex
All
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

We wanted to test the hypothesis that acute treatment with atorvastatin changes renal sodium handling, renal hemodynamics, tubular function and vasoactive hormones in healthy humans during normal and high sodium intake.

Detailed description

We wanted to test the hypothesis that acute treatment with atorvastatin changes renal sodium handling, renal hemodynamics, tubular function and vasoactive hormones in healthy humans during normal and high sodium intake. We wanted to analyze if changes in renal hemodynamics, tubular function, hormones, blood pressure and HR under acute treatment with atorvastatin depends on sodium intake.

Conditions

Interventions

TypeNameDescription
DRUGAtorvastatin80 mg atorvastatin on two following days each

Timeline

Start date
2007-01-01
Primary completion
2007-10-01
Completion
2007-10-01
First posted
2008-05-15
Last updated
2008-05-15

Locations

2 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00678184. Inclusion in this directory is not an endorsement.